These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4028912)

  • 1. Diagnostic and prognostic implications of plasma amino acid determinations in chronic active hepatitis.
    Shiels MT; Czaja AJ; Ludwig J; McCullough AJ; Jones JD; Go VL
    Dig Dis Sci; 1985 Sep; 30(9):819-23. PubMed ID: 4028912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease.
    McCullough AJ; Czaja AJ; Jones JD; Go VL
    Gastroenterology; 1981 Oct; 81(4):645-52. PubMed ID: 7262510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis.
    Czaja AJ; Davis GL; Ludwig J; Taswell HF
    Hepatology; 1984; 4(4):622-7. PubMed ID: 6745850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine versus prednisone in chronic active hepatitis and non-alcoholic cirrhosis. Effect on survival and activity.
    Scand J Gastroenterol; 1982 Sep; 17(6):817-24. PubMed ID: 6760378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index.
    Kano T; Nagaki M; Takahashi T; Ohnishi H; Saitoh K; Kimura K; Muto Y
    Gastroenterol Jpn; 1991 Jun; 26(3):344-9. PubMed ID: 1889691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of alcohol on branched-chain amino acid/tyrosine molar ratio in patients with cirrhosis.
    Suzuki H; Mamata Y; Mizuno H; Tominaga T; Suga M; Suemori S; Sato A; Suzuki M
    Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):137S-140S. PubMed ID: 9622391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
    Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
    Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of chronic active hepatitis and the development of cirrhosis.
    Vegnente A; Larcher VF; Mowat AP; Portmann B; Williams R
    Arch Dis Child; 1984 Apr; 59(4):330-5. PubMed ID: 6721559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis.
    Davis GL; Czaja AJ; Baggenstoss AH; Taswell HF
    Mayo Clin Proc; 1982 May; 57(5):303-9. PubMed ID: 7043106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.
    Hegarty JE; Nouri Aria KT; Portmann B; Eddleston AL; Williams R
    Hepatology; 1983; 3(5):685-9. PubMed ID: 6618435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL; Czaja AJ; Ludwig J
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.
    Sherman KE; Narkewicz M; Pinto PC
    J Hepatol; 1994 Dec; 21(6):1040-7. PubMed ID: 7699225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results and prognostic factors in the treatment of chronic active hepatitis with prednisone and azathioprine].
    Jorge AD; Sánchez D
    Acta Gastroenterol Latinoam; 1985; 15(4):233-41. PubMed ID: 3842554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune chronic active hepatitis in childhood.
    Maggiore G; Bernard O; Hadchouel M; Hadchouel P; Odievre M; Alagille D
    J Pediatr; 1984 Jun; 104(6):839-44. PubMed ID: 6726513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis.
    Kenny RP; Czaja AJ; Ludwig J; Dickson ER
    Dig Dis Sci; 1986 Jul; 31(7):705-11. PubMed ID: 3720467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.